Viking Therapeutics, Inc.
Total Trades
102
Buys
2
Sells
50
Largest Trade
N/A
Insiders
8
Institutional Funds
348
Inst. Value
$1M+
Activist Filings
25
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| ZANTE GREG | CFO | GRANT | N/A | 73K | — | Jan 6, 2026 |
| ZANTE GREG | CFO | SELL | $1M+ | 58K | $32.90 | Jan 6, 2026 |
| Mancini Marianna | COO | SELL | $1M+ | 58K | $32.98 | Jan 6, 2026 |
| Mancini Marianna | COO | GRANT | N/A | 73K | — | Jan 6, 2026 |
| Lian Brian | President & CEO | GRANT | N/A | 302K | — | Jan 6, 2026 |
| Lian Brian | President & CEO | SELL | $1M+ | 233K | $32.96 | Jan 6, 2026 |
| FOEHR MATTHEW W | Director | GRANT | N/A | 3K | — | Jan 6, 2026 |
| FOEHR MATTHEW W | Director | EXERCISE | $50K–$100K | 16K | $3.33 | Jan 6, 2026 |
| FOEHR MATTHEW W | Director | SELL | $500K+ | 16K | $35.11 | Jan 6, 2026 |
| Mancini Marianna | COO | SELL | $100K–$500K | 6K | $35.00 | Oct 28, 2025 |
| Mancini Marianna | COO | GRANT | N/A | 11K | — | Oct 28, 2025 |
| Rowland Charles A Jr | Director | GRANT | $100K–$500K | 60K | $5.11 | Oct 28, 2025 |
| Rowland Charles A Jr | Director | SELL | $1M+ | 60K | $35.57 | Oct 28, 2025 |
| Lian Brian | President & CEO | GRANT | N/A | 70K | — | Oct 28, 2025 |
| Lian Brian | President & CEO | SELL | $1M+ | 39K | $35.01 | Oct 28, 2025 |
| ZANTE GREG | CFO | SELL | $100K–$500K | 6K | $35.00 | Oct 28, 2025 |
| ZANTE GREG | CFO | GRANT | N/A | 11K | — | Oct 28, 2025 |
| Lian Brian | President & CEO | GRANT | N/A | 48K | — | Jul 3, 2025 |
| Lian Brian | President & CEO | SELL | $500K+ | 27K | $27.80 | Jul 3, 2025 |
| ZANTE GREG | CFO | SELL | $100K–$500K | 4K | $27.76 | Jul 3, 2025 |
| ZANTE GREG | CFO | GRANT | N/A | 8K | — | Jul 3, 2025 |
| Mancini Marianna | COO | SELL | $100K–$500K | 4K | $27.77 | Jul 3, 2025 |
| Mancini Marianna | COO | GRANT | N/A | 8K | — | Jul 3, 2025 |
| Rouan Sarah Kathryn | Director | BUY | $15K–$50K | 1K | $24.15 | Apr 2, 2025 |
| Lian Brian | President & CEO | GRANT | N/A | 256K | — | Jan 7, 2025 |
| Lian Brian | President & CEO | SELL | $1M+ | 194K | $42.75 | Jan 7, 2025 |
| Mancini Marianna | COO | GRANT | N/A | 66K | — | Jan 7, 2025 |
| Mancini Marianna | COO | SELL | $1M+ | 54K | $42.75 | Jan 7, 2025 |
| ZANTE GREG | CFO | SELL | $1M+ | 50K | $42.75 | Jan 7, 2025 |
| ZANTE GREG | CFO | GRANT | N/A | 66K | — | Jan 7, 2025 |
| MACARTNEY LAWSON | Director | EXERCISE | $1K–$15K | 2K | $5.80 | Nov 8, 2024 |
| MACARTNEY LAWSON | Director | SELL | $100K–$500K | 2K | $68.67 | Nov 8, 2024 |
| ZANTE GREG | CFO | SELL | $1M+ | 132K | $76.61 | Oct 29, 2024 |
| ZANTE GREG | CFO | EXERCISE | $500K+ | 94K | $7.49 | Oct 29, 2024 |
| Rouan Sarah Kathryn | Director | SELL | $500K+ | 11K | $80.89 | Oct 25, 2024 |
| Rouan Sarah Kathryn | Director | EXERCISE | $50K–$100K | 11K | $4.88 | Oct 25, 2024 |
| SINGLETON J MATTHEW | Director | EXERCISE | $50K–$100K | 16K | $4.48 | Oct 25, 2024 |
| SINGLETON J MATTHEW | Director | SELL | $1M+ | 16K | $79.50 | Oct 25, 2024 |
| SINGLETON J MATTHEW | Director | EXERCISE | $1K–$15K | 10K | $1.19 | Sep 21, 2024 |
| SINGLETON J MATTHEW | Director | SELL | $500K+ | 10K | $69.50 | Sep 21, 2024 |
| Lian Brian | President & CEO | EXERCISE | $1M+ | 166K | $7.77 | Sep 21, 2024 |
| Lian Brian | President & CEO | SELL | $1M+ | 216K | $70.83 | Sep 21, 2024 |
| Lian Brian | President & CEO | SELL | $50K–$100K | 1K | $69.90 | Aug 22, 2024 |
| Lian Brian | President & CEO | EXERCISE | $1K–$15K | 1K | $7.77 | Aug 22, 2024 |
| SINGLETON J MATTHEW | Director | EXERCISE | $1K–$15K | 6K | $1.19 | Aug 22, 2024 |
| SINGLETON J MATTHEW | Director | SELL | $100K–$500K | 6K | $69.72 | Aug 22, 2024 |
| Lian Brian | President & CEO | SELL | $1M+ | 113K | $65.80 | Aug 20, 2024 |
| Lian Brian | President & CEO | EXERCISE | $500K+ | 113K | $7.77 | Aug 20, 2024 |
| SINGLETON J MATTHEW | Director | SELL | $500K+ | 16K | $62.22 | Aug 20, 2024 |
| SINGLETON J MATTHEW | Director | EXERCISE | $50K–$100K | 16K | $3.33 | Aug 20, 2024 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 348 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| STATE STREET CORP | 4.4M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 1.7M | $1M+ | SH |
| BNP PARIBAS FINANCIAL MARKETS | 993K | $1M+ | SH |
| Pictet Asset Management Holding SA | 753K | $1M+ | SH |
| Artia Global Partners LP | 719K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 700K | $1M+ | SH |
| Connor, Clark & Lunn Investment Management Ltd. | 519K | $1M+ | SH |
| BARCLAYS PLC | 517K | $1M+ | SH |
| PRINCIPAL FINANCIAL GROUP INC | 511K | $1M+ | SH |
| GOLDMAN SACHS GROUP INC | 503K | $1M+ | SH |
| TANG CAPITAL MANAGEMENT LLC | 500K | $1M+ | SH |
| DIMENSIONAL FUND ADVISORS LP | 449K | $1M+ | SH |
| Clearbridge Investments, LLC | 445K | $1M+ | SH |
| RAYMOND JAMES FINANCIAL INC | 441K | $1M+ | SH |
| First Washington CORP | 388K | $1M+ | SH |
| STIFEL FINANCIAL CORP | 337K | $1M+ | SH |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 330K | $1M+ | SH |
| Steward Partners Investment Advisory, LLC | 316K | $1M+ | SH |
| Point72 Asset Management, L.P. | 313K | $1M+ | SH |
| AMERICAN CENTURY COMPANIES INC | 305K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Nov 5, 2025
5.1%
5.8M shares
SC 13G/A · Aug 6, 2025
8.7%
9.8M shares
SC 13G/A · May 12, 2025
10.0%
11.2M shares
SC 13G/A · Apr 23, 2025
4.5%
5.0M shares
SC 13G · Feb 4, 2025
5.3%
5.9M shares
SC 13G/A · Nov 14, 2024
0.6%
722K shares
SC 13G/A · Nov 12, 2024
9.2%
10.2M shares
SC 13G/A · Nov 4, 2024
9.2%
10.2M shares
STATE STREET CORPORATION 04-2456637
SC 13G/A · Oct 18, 2024
4.2%
4.7M shares
SC 13G/A · Aug 7, 2024
4.9%
5.5M shares
SC 13G/A · Feb 14, 2024
5.1%
5.1M shares
The Vanguard Group - 23-1945930
SC 13G · Feb 13, 2024
5.4%
5.4M shares
SC 13G · Jan 26, 2024
7.6%
7.6M shares
STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON 04-2456637
SC 13G/A · Jan 24, 2024
5.7%
0 shares
SC 13G/A · Jan 12, 2024
0.4%
404K shares
SC 13G · Nov 2, 2023
5.9%
5.9M shares
SC 13G · Apr 10, 2023
11.4%
10.9M shares
Ligand Pharmaceuticals Incorporated
SC 13D/A · Mar 30, 2023
4.6%
3.6M shares
ArrowMark Colorado Holdings, LLC
SC 13G/A · Feb 14, 2023
0.0%
16K shares
Ligand Pharmaceuticals Incorporated
SC 13D/A · Feb 9, 2023
7.9%
6.1M shares
STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON 04-2456637
SC 13G/A · Feb 3, 2023
0.3%
0 shares
SC 13G · Jan 3, 2023
6.3%
4.8M shares
SC 13G · Jul 8, 2022
1.8%
1.4M shares
ArrowMark Colorado Holdings, LLC
SC 13G/A · Feb 14, 2022
9.0%
7.1M shares
STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON 04-2456637
SC 13G/A · Feb 12, 2022
5.3%
0 shares